Login / Signup

Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing Platform.

Norbert BanyiDeepu AlexCurtis HughesmanKelly McNeilDiana N IonescuCarmen MaStephen YipBarbara L Melosky
Published in: Current oncology (Toronto, Ont.) (2022)
Using the Idylla EGFR test as part of the molecular testing repertoire in advanced-stage NSCLC patients could significantly reduce TTT.
Keyphrases